Myomo, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Myomo, Inc. (MYO) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $122.71 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-11.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2022-03-11
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2020-09-30 was $888.00, a 93.89% decline year-over-year.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2020-06-30 was $39.72K, a 60.06% decline year-over-year.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2020-03-31 was $82.10K, a 95.62% increase year-over-year.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2020 was $122.71K, a 36.91% decline from fiscal 2019.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2019 was $194.49K.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2018 was -$36.27K, a 131.05% decline from fiscal 2017.
- Myomo, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2017 was $116.80K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $888.00 derived: sum of 2 quarters · filed 2022-03-11 | $40.60K derived: sum of 3 quarters · filed 2022-03-11 | $122.71K 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $888.00 10-Q · filed 2021-11-10 | $40.60K derived: sum of 2 quarters · filed 2021-11-10 | $122.71K 10-Q · filed 2021-11-10 | $161.24K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $39.72K 10-Q · filed 2021-08-09 | $121.82K 10-Q · filed 2021-08-09 | $160.35K derived: sum of 3 quarters · filed 2021-08-09 | $174.88K derived: sum of 4 quarters · filed 2021-08-09 | ||||
| 2020-03-31 | $82.10K 10-Q · filed 2021-05-05 | $120.63K derived: sum of 2 quarters · filed 2021-05-05 | $135.17K derived: sum of 3 quarters · filed 2021-05-05 | $234.62K derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $38.53K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $53.07K derived: sum of 2 quarters · filed 2021-03-10 | $152.51K derived: sum of 3 quarters · filed 2021-03-10 | $194.49K 10-K · filed 2021-03-10 | -$194.49K 10-K · filed 2020-03-13 | |||
| 2019-09-30 | $14.54K 10-Q · filed 2020-11-10 | $113.98K derived: sum of 2 quarters · filed 2020-11-10 | $155.96K 10-Q · filed 2020-11-10 | $88.41K derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $99.45K 10-Q · filed 2020-08-10 | $141.42K 10-Q · filed 2020-08-10 | $73.87K derived: sum of 3 quarters · filed 2020-08-10 | $87.18K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $41.97K 10-Q · filed 2020-05-14 | -$25.58K derived: sum of 2 quarters · filed 2020-05-14 | -$12.27K derived: sum of 3 quarters · filed 2020-05-14 | -$9.61K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$67.55K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$54.24K derived: sum of 2 quarters · filed 2020-03-13 | -$51.58K derived: sum of 3 quarters · filed 2020-03-13 | -$36.27K 10-K · filed 2020-03-13 | $36.27K 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $13.31K 10-Q · filed 2019-11-12 | $15.97K derived: sum of 2 quarters · filed 2019-11-12 | $31.28K 10-Q · filed 2019-11-12 | $83.71K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $2.66K 10-Q · filed 2019-08-08 | $17.97K 10-Q · filed 2019-08-08 | $70.40K derived: sum of 3 quarters · filed 2019-08-08 | $289.77K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $15.31K 10-Q · filed 2019-05-14 | $67.74K derived: sum of 2 quarters · filed 2019-05-14 | $287.11K derived: sum of 3 quarters · filed 2019-05-14 | $156.95K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $52.43K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $271.80K derived: sum of 2 quarters · filed 2019-03-12 | $141.64K derived: sum of 3 quarters · filed 2019-03-12 | $116.80K 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $219.37K 10-Q · filed 2018-11-07 | -$219.37K 10-Q · filed 2017-11-08 | $89.21K derived: sum of 2 quarters · filed 2018-11-07 | $64.37K 10-Q · filed 2018-11-07 | -$64.37K 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | -$130.16K 10-Q · filed 2018-08-08 | $130.16K 10-Q · filed 2017-08-14 | -$155.01K 10-Q · filed 2018-08-08 | $155.01K 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | -$24.85K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |